Device Trial Radar · NCT00887055
OPTIMA Bi-ventricular Capture Verification Study
Last checked: Nov 20, 2026Latest source record: Jun 29, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Guidant CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 23, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize the morphology (shape) of the intracardiac electrograms(EGM) from patients with a resynchronization therapy device.
Conditions
- Heart Failure
Interventions
CRT deviceDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hopital Laval
Ste-Foy, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.